ETRA

8.2807.38%
GS

Gary S. Koe

Chief Technology Officer

Mr. Gary S. Koe, Ph.D., is Chief Technology Officer of Electra Therapeutics, Inc. since May 2025 and also served as Senior VP & Head of Technical Operations from 2025 to 2025. He has extensive biopharmaceutical development and large-scale biologics manufacturing experience. Prior to joining Electra Therapeutics, he served as Head of Technical Operations at Aravive, Inc., working on the large-scale manufacture of a novel affinity Fc-sAXL fusion protein. Prior to Aravive, he held positions of increasing responsibility at biopharmaceutical companies, including Genentech, Valentis, Revance and Versartis. He has led the scale-up, technology transfer, manufacturing and QC testing of several clinical biologics and more than ten manufacturing facilities (in-house and CDMOs). He has Ph.D. in Chemical Engineering from University of California, Los Angeles and has B.S. in Chemical Engineering from University of California, Davis.

Positions